What's New
Merger announcement
2024.06.11
June 2024
WATANABE CHEMICAL INDUSTRIES, LTD.
President and CEO
Koichi Hiwatashi
Merger announcement
WATANABE CHEMICAL INDUSTRIES LTD. announces the absorption type of merger with its subsidiary, HAKKO TSUSHO CO., LTD., on 1st June 2024. WATANABE CHEMICAL INDUSTRIES, LTD. succeeded substantially all of the assets, liabilities, and contractual status of HAKKO TSUSHO CO., LTD.
All businesses and functions of HAKKO TSUSHO CO., LTD. ‘s headquarters and Kashima plant will continue as before as the HAKKO TSUSHO division of WATANABE CHEMICAL INDUSTRIES, LTD.
We will provide ever-better products and services through this merger and appreciate your continued support.
1.Purpose of the merger
The integration of WATANABE CHEMICAL INDUSTRIES, LTD., which specializes in high-mix, low-volume production of amino acid derivatives and reagents for peptide synthesis, and HAKKO TSUSHO CO., LTD., which has extensive industrialization experience and facilities capable of commercial production, will enable the handling of gram scale to ton scale production and high synergy is expected. Sharing production facilities and technologies will also improve management efficiency.
2.Outline of the merger
| Date of merger agreement | 1st April 2024 |
| Effective date | 1st June 2024 |
3.Method of the merger
WATANABE CHEMICAL INDUSTRIES, LTD. is the surviving company and HAKKO TSUSHO CO., LTD. is the dissolving company.
4.Allocations relating to the merger
Because this is a merger of a wholly owned subsidiary, no shares were issued.
5.Overview of the Parties to the merger
| The surviving company | The dissolving company | |
| Name | WATANABE CHEMICAL INDUSTRIES, LTD. | HAKKO TSUSHO CO., LTD. |
| Principal office | 2-2-5 Sakaimachi Naka-ku, Hiroshima-city, Hiroshima | 2-7-6 Kayabacyo-Nihonbashi, Chuo-ku,Tokyo |
| Name and title of representatives | Koichi Hiwatashi
President and CEO |
Koichi Hiwatashi
President and CEO |
| Principal businesses | Manufacturing & selling of reagents for peptide synthesis and amino acid derivatives | Contract/custom manufacturing including synthetic research of development products, and domestic sales and import/export of chemicals |
| Capital amount | 20 million yen | 20 million yen |
| Stake holder | Asahi Techno Research Co., Ltd. 100% | WATANABE CHEMICAL INDUSTRIES, LTD. 100% |
| Fiscal term | June | May |
6.Status after the merger (after 1st June 2024)
| The surviving company | |
| Name | WATANABE CHEMICAL INDUSTRIES, LTD. |
| Principal office | 2-2-5 Sakaimachi Naka-ku, Hiroshima-city, Hiroshima |
| Name and title of representative | Koichi Hiwatashi
President and CEO |
| Principal businesses | Manufacturing & selling of reagents for peptide synthesis and amino acid derivatives
(HAKKO TSUSHO division of WATANABE CHEMICAL INDUSTRIES, LTD.) Contract/custom manufacturing including synthetic research of development products, and domestic sales and import/export of chemicals |
| Capital amount | 20 million yen |
| Stake holder | Asahi Techno Research Co., Ltd. 100% |
| Fiscal term | June |